SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.351
AS - Asia 10.342
EU - Europa 5.203
SA - Sud America 1.633
AF - Africa 211
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 34.776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.949
SG - Singapore 3.733
CN - Cina 2.470
BR - Brasile 1.251
VN - Vietnam 1.056
IT - Italia 1.003
UA - Ucraina 994
HK - Hong Kong 879
DE - Germania 740
TR - Turchia 597
GB - Regno Unito 544
BD - Bangladesh 409
FR - Francia 377
FI - Finlandia 343
SE - Svezia 305
JP - Giappone 293
IN - India 290
RU - Federazione Russa 258
PL - Polonia 240
CA - Canada 174
MX - Messico 160
AR - Argentina 136
ID - Indonesia 112
NL - Olanda 85
PK - Pakistan 81
CO - Colombia 73
ZA - Sudafrica 67
IQ - Iraq 65
ES - Italia 55
EC - Ecuador 54
AT - Austria 40
CL - Cile 40
UZ - Uzbekistan 38
BE - Belgio 36
LT - Lituania 36
IR - Iran 35
PH - Filippine 34
SA - Arabia Saudita 31
CZ - Repubblica Ceca 30
EG - Egitto 30
TW - Taiwan 29
PY - Paraguay 28
VE - Venezuela 27
MA - Marocco 26
AE - Emirati Arabi Uniti 25
MY - Malesia 25
KR - Corea 23
KE - Kenya 21
TN - Tunisia 20
AU - Australia 16
IE - Irlanda 16
TH - Thailandia 16
JM - Giamaica 15
DZ - Algeria 14
CH - Svizzera 13
CR - Costa Rica 13
NP - Nepal 13
PE - Perù 12
AL - Albania 11
LB - Libano 10
NZ - Nuova Zelanda 10
DO - Repubblica Dominicana 9
ET - Etiopia 9
KZ - Kazakistan 9
RS - Serbia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
IL - Israele 8
JO - Giordania 8
PS - Palestinian Territory 8
RO - Romania 8
GR - Grecia 7
HN - Honduras 7
BA - Bosnia-Erzegovina 6
BO - Bolivia 6
HU - Ungheria 6
QA - Qatar 6
CI - Costa d'Avorio 5
DK - Danimarca 5
KG - Kirghizistan 5
OM - Oman 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
GE - Georgia 4
GT - Guatemala 4
MK - Macedonia 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
EU - Europa 3
KW - Kuwait 3
ME - Montenegro 3
MN - Mongolia 3
NG - Nigeria 3
NI - Nicaragua 3
PA - Panama 3
SC - Seychelles 3
SN - Senegal 3
UY - Uruguay 3
Totale 34.736
Salva come PNG Salva come JPEG
Città #
Singapore 2.329
Ashburn 1.811
Woodbridge 1.461
Fairfield 1.340
San Jose 1.134
Jacksonville 1.019
Houston 1.016
Chandler 855
Hong Kong 855
Santa Clara 807
Beijing 703
Ann Arbor 622
Wilmington 559
Seattle 540
Cambridge 480
Ho Chi Minh City 374
Izmir 338
Nanjing 299
Hanoi 271
Tokyo 265
New York 256
Ferrara 244
Los Angeles 243
Princeton 228
Warsaw 226
Dallas 201
Boardman 189
Lauterbourg 188
Council Bluffs 182
The Dalles 150
Milan 137
San Diego 122
Munich 117
Helsinki 110
São Paulo 109
Addison 104
Nanchang 99
Mexico City 95
Shenyang 81
Orem 80
Hefei 77
Shanghai 76
Hebei 74
London 72
Buffalo 69
Jakarta 65
Tianjin 64
Brooklyn 60
Chicago 59
Rio de Janeiro 57
Changsha 56
Falls Church 49
Bremen 47
Chennai 47
Frankfurt am Main 47
Moscow 47
Montreal 46
Redwood City 46
San Mateo 46
Dearborn 44
Rome 42
Toronto 41
Da Nang 40
Atlanta 38
Turku 38
Amsterdam 37
Jiaxing 35
Kunming 35
Falkenstein 34
Tashkent 34
Bologna 33
Johannesburg 33
Norwalk 33
Phoenix 32
Stockholm 32
Denver 31
San Francisco 31
Manchester 30
Ankara 28
Mountain View 28
Haiphong 27
Jinan 27
Belo Horizonte 26
Boston 26
Guangzhou 26
Medellín 25
Poplar 25
Vienna 25
Brussels 24
Dhaka 24
Hải Dương 24
Philadelphia 24
Chongqing 23
Mumbai 23
Nuremberg 23
Washington 23
Zhengzhou 23
Naples 22
Baghdad 21
Santiago 21
Totale 22.554
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 390
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 290
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 287
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 286
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 265
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 262
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 251
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 247
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 247
Conjugation of aspirin with vitamin C: uptake and stability studies 241
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 234
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 222
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 221
Physicochemical stability of cabazitaxel and docetaxel solutions 221
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 220
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 219
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 217
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 213
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 212
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 211
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 206
Binding thermodynamics at A1 and A2A adenosine receptors 205
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 205
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 205
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 204
Hyaluronic acid based-hybrid nanoparticles for targeted nose- to-brain delivery of dimethyl fumarate 203
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 202
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 202
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 201
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 201
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 200
Binding thermodynamics of 5-HT(1A) receptor ligands 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 199
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 196
Conformational Aspects of Human Formyl-peptide Receptor Agonists 196
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 195
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 193
Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way 189
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 189
Conformational aspects of human formylpeptide receptor antagonists 188
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 186
Progress in drug delivery to the central nervous system by the prodrug approach 186
Bile acids modulation of nanoparticle macrophage uptake 186
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 185
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 185
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 185
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 184
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 183
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 183
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 182
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 182
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 180
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 180
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 179
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 176
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 175
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 175
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 175
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 174
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 174
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 174
Binding thermodynamics of adenosine A2a receptor ligands 174
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 171
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 171
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 171
N6-cyclopentyladenosine : selective brain targeting by nasal administration of microparticles 168
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 168
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 167
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment 167
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 166
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 165
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 164
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 163
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 163
Design and formulation of Eudragit-coated zein/pectin nanoparticles for the colon delivery of resveratrol 162
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 160
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 160
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 160
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 159
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 158
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 157
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 157
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 157
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 157
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 157
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 156
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 156
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 156
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 155
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors 155
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 155
Coniugati dell’acido ascorbico ad attività neurotropica. 153
Nasal administration and brain targeting of an antiischemic agent 152
Materie Prime: Eccipienti 152
Temperature dependence and GABA modulation of β-carboline binding to rat cerebellum benzodiazepine receptors 152
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 152
Risedronate pharmacokinetic studies after oral administration to rats of loaded TiO2 nanoparticles 150
Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers 149
Totale 19.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.535
Totale 156.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.984 50 229 148 121 88 85 77 105 76 164 182 659
2022/20231.979 227 94 53 256 380 308 59 156 250 15 115 66
2023/2024994 121 133 57 24 94 111 35 39 15 19 33 313
2024/20254.803 98 91 382 190 613 431 192 295 726 583 712 490
2025/202613.791 1.245 583 1.173 1.706 1.767 842 1.474 813 1.420 1.585 660 523
2026/2027165 165 0 0 0 0 0 0 0 0 0 0 0
Totale 35.104